COMET | Jotup

Akima Secures $750M Contract to Bolster U.S. Air Force IT Modernization Initiatives

Retrieved on:

Dienstag, April 23, 2024

Air force, Partnership, Springfield–Beckley Municipal Airport, Federation, COMET, USAF, Communication, IDIQ, AGT, VTC

The award has a 10-year period of performance and a total contract value of $750 million.

Key Points:

The award has a 10-year period of performance and a total contract value of $750 million.
"We're thrilled to announce our latest project in partnership with the U.S. Air Force.
"By strategically modernizing the Air Force's IT efforts, we'll aid the USAF in doing what it does best: accomplishing the impossible each and every day."
These services will be delivered at Wright-Patterson Air Force Base, Ohio and Springfield Air National Guard Base in Springfield, Ohio; and are scheduled for completion by February 2034.

BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS

Retrieved on:

Dienstag, April 23, 2024

ISH, Trial, Investment, Research, Bio-Techne, COMET, Unified Patent Court, Acquisition, Intellectual property, ACD

MINNEAPOLIS, April 23, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that it has taken legal action in the Unified Patent Court in Europe to halt the infringement of its patented RNAscope® ISH technology by Molecular Instruments, Inc.

Key Points:

Bio-Techne enforces intellectual property for gold standard RNAscope® ISH technology in spatial biology research and clinical applications.
RNAscope is the most referenced technology in the industry, with its rapidly growing portfolio of peer-reviewed publications recently surpassing 10,000.
In its lawsuit filed in the Unified Patent Court (a pan-European forum for resolving patent disputes), in the Netherlands Local Division of the Court of First Instance in The Hague, Bio-Techne alleges that Molecular Instruments' HCR 3.0 technology infringes ACD's European Patents 1,910,572 and 2,500,439.
The lawsuit seeks damages and injunctive relief requiring Molecular Instruments to stop infringing ACD's patents in key European markets.

Life Cycle Analysis by Planet FWD Defines Sustainability of COMET's Arrabina™ Prebiotic Fibers

Retrieved on:

Montag, April 22, 2024

Innova, Snack, Health, LCA, Certification, COMET, See, Carbon, Recycling

SCHAUMBURG, Ill., April 22, 2024 /PRNewswire/ -- On this Earth Day, COMET, manufacturer of Arrabina™ dietary fibers, announces results of a life cycle analysis (LCA) that highlights the efficacy of their sustainable practices and the reduced carbon footprint of upcycled ingredients.

Key Points:

This assessment undertaken by Planet FWD , a leader in the LCA industry, measured the complete cradle-to-gate life cycle of the ingredient with a comparison of Arrabina™ to chicory root-based inulin and other similar dietary fibers.
(See Image 2)
Using Arrabina™ in consumer products can reduce emissions, contributing to the overall sustainability of the product life cycle.
Andrew Richard, COMET Chief Technology Officer, is the innovator of the upcycling technology that brought Arrabina™ dietary fibers to market.
This comparison references Product LCA cradle-to-gate analysis conducted by Planet FWD on November 2, 2023 and has been reviewed for comparable units of analysis, scope, and methodology.

BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES

Retrieved on:

Donnerstag, März 28, 2024

Health, COMET, Drug discovery, Partnership, Research, Bio-Techne, Disease, Diagnosis, Workflow, Nikon Instruments, Microscope

MINNEAPOLIS, March 28, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce that Lunaphore , part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. (Nikon) to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.

Key Points:

MINNEAPOLIS, March 28, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce that Lunaphore , part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. (Nikon) to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.
Together, Lunaphore and the Nikon BioImaging Lab will be able to leverage their complementary expertise in microscopy-based imaging and analysis to bring COMET technology and spatial biology to the greater scientific community.
Researchers and clinicians can leverage the universal end-to-end product suite to unlock the full potential of spatial biology for their research objectives.
"Spatial biology is a dynamic area of innovation that will shed new light on healthcare and further our understanding of human disease and health."

SMX Announces Joint Venture with Fusion Technology

Retrieved on:

Donnerstag, Februar 29, 2024

NASA, ITES, Partnership, Small business, Growth, JV, COMET, Federation

The joint venture will provide both member companies with new opportunities across the Federal Government.

Key Points:

The joint venture will provide both member companies with new opportunities across the Federal Government.
As a joint venture, it is positioned for upcoming strategic GWACs including NASA SEWP, ITES 4S, OASIS+, and COMET.
SMX and Fusion will collaborate on their shared capabilities of cloud migration and integration, advanced infrastructure, life cycle support services, IT operation and maintenance, to better support our clients’ mission success.
This agreement also positions Fusion for new growth opportunities in cloud, data analytics, and digital transformation.

BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS

Retrieved on:

Montag, Januar 29, 2024

Patient, Research, Bio-Techne, Bladder cancer, Mass meeting, RNA, Poster, Workflow, Protein, Biomarker, Data analysis, Messenger, COMET, Publication, ACD, Vaccine

MINNEAPOLIS, Jan. 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow. Optimized for same-slide detection of protein and RNA biomarkers with unparalleled sensitivity and tissue morphology, the newly developed RNAscope spatial multiomics workflow is compatible with both manual and automated assays. ACD's novel protease-free RNAscope workflow is incorporated in Bio-Techne's recently announced best-in-class multiomics application on Lunaphore's COMET platform.

Key Points:

Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using industry-leading RNAscope™ technology.
MINNEAPOLIS, Jan. 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD) , a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.
Optimized for same-slide detection of protein and RNA biomarkers with unparalleled sensitivity and tissue morphology, the newly developed RNAscope spatial multiomics workflow is compatible with both manual and automated assays.
ACD's novel protease-free RNAscope workflow is incorporated in Bio-Techne's recently announced best-in-class multiomics application on Lunaphore's COMET platform.

LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION

Retrieved on:

Donnerstag, Januar 25, 2024

Research, IHC, Mass meeting, RNA, Workflow, Drug development, Antibody, COMET, ACD, Medical imaging

MINNEAPOLIS, Jan. 25, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD) , will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

Key Points:

MINNEAPOLIS, Jan. 25, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD) , will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.
"Combining ACD's leading RNA detection technology with Lunaphore's fully automated high-throughput protein detection capabilities on the COMET system enables a best-in-class multiomics spatial biology solution," commented Kim Kelderman, Bio-Techne's Chief Operating Officer.
With this cutting-edge application, we continue to lead the way and shape the future of the spatial biology market."
To book a meeting or find out more about Lunaphore and ACD's presence at the conference, please visit Lunaphore's website.

COMET Highlights "4 for 10" Gut Health Trends for 2024

Retrieved on:

Donnerstag, Januar 11, 2024

Drink, Woman, Food, Life, Menopause, Pregnancy, COMET, Millennials, Appetite, Dietary supplement

SCHAUMBURG, Ill., Jan. 11, 2024 /PRNewswire/ -- COMET, the manufacturer of Arrabina™ prebiotic dietary fibers, has just released its trend predictions that highlight the most robust opportunities for microbiome-enhancing foods, beverages, and supplements in the year ahead.

Key Points:

"We've looked at all aspects of the target biotic consumer including what health motivators are driving them right now, generational and gender differences and what they see as perceived value."
"Interestingly, this year's microbiome predictions have more to do with physical and social trends than they do with gut health, and this is a true sign of the times.
Below are topline details from COMET's four Macro Market Trends and a bit about what that means for the biotics industry.
Reach out to learn more about directions that help uplift slowing sales in the supplement industry.

LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS

Retrieved on:

Donnerstag, Dezember 14, 2023

Research, Spatial, Health, COMET, SIB, AI, Bio-Techne, Medical imaging

MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore , a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics , have been awarded Innosuisse funding for an innovation project.

Key Points:

MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore , a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics , have been awarded Innosuisse funding for an innovation project.
The collaboration aims to develop novel AI-based assay development tools for spatial biology on Lunaphore's COMET™ to further accelerate the adoption of multiplex sequential immunofluorescence (seqIF™) technology in research.
Spatial biology utilizes detailed tissue analysis and intracellular interactions to enable profound insights in cancer biology, immuno-oncology, and other research fields.
However, technical hurdles still stand in the way of spatial biology technologies entering clinics and becoming guiding tools for personalized therapies.

Comtech Receives $20.0 Million Order from Spectra Group to Service Multiple NATO and European Regional Orders for Next Generation Troposcatter Systems

Retrieved on:

Donnerstag, November 9, 2023

The order will allow Spectra Group, the appointed regional distributor of Comtech’s Compact Over-the-Horizon Transportable Terminal (COMET), to service multiple orders already received, and several expected follow-on orders from undisclosed customers in the NATO and European regions.

Key Points:

The order will allow Spectra Group, the appointed regional distributor of Comtech’s Compact Over-the-Horizon Transportable Terminal (COMET), to service multiple orders already received, and several expected follow-on orders from undisclosed customers in the NATO and European regions.
“Through this order from Spectra Group, Comtech is helping expand network agnostic, secure, and interoperable BLOS communications capabilities for our NATO and EU regional partners,” said Ken Peterman, President and CEO, Comtech.
In September 2023, Spectra Group announced the receipt of a $8.0 million order from UK MoD to equip 3 (UK) Division with Comtech’s COMET systems.
Spectra Group is now close to receiving additional orders for large quantities of Comtech’s COMET systems from other key NATO and European regional customers.